Insulin Lilly Humalog cartouches 3,0 ml, solution injectable

7680535530369 CH-53553 Injektionslösung
Insulin Lilly Humalog cartouches 3,0 ml, solution injectable
Insulin Lilly Humalog cartouches 3,0 ml, solution injectable
Insulin Lilly Humalog cartouches 3,0 ml, solution injectable
1 / 3
google

Article details

Package size
5 x 3,0
Selling units
5
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/11/2023
Patient information leaflet
Français
10/11/2023
Patient information leaflet
Italien
10/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 UI Substance Wirkstoff (Principe actif)
(N/A)
3.5 MG Substance WIIS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.5 MG Substance HBESI

Reimbursement information

Public price
CHF 53.65
Specialties list
Yes
Generic
No
SL addition date: 15/03/1998

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
53553
Drug name
Insulin Lilly Humalog cartouches, solution injectable
Galenic form
LSILP
ATC Code
A10AB04
Authorization status
Z
Dispensing category
B
First authorization
23/11/1995
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Package details

Description (FR)
HUMALOG sol inj 100 UI/ml p pen 5 cartouche 3 ml
Description (DE)
HUMALOG Inj Lös 100 IE/ml f Pen 5 Patrone 3 ml
Market launch
20/08/1997
Narcotic (BTM)
No